BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2008
View Archived Issues
CytRx unveils strategy for clinical development of pipeline assets
Read More
Solbec changes name to Freedom Eye
Read More
Novel analgesic agents reported in recent patent literature
Read More
New therapeutic agents for AD and other neurological disorders reported in recent patents
Read More
Genentech initiates phase II hedgehog pathway inhibitor trial in ovarian cancer
Read More
CHMP recommends approval of Schering-Plough's Temodal for certain primary brain tumors
Read More
AstraZeneca and Bristol-Myers expand dapagliflozin collaboration to include Japan
Read More
Genentech licenses ImmunoGen's TAP technology to develop anticancer therapeutics
Read More
4SC completes dosing and reports interim results from phase I clinical trial of 4SC-201
Read More
FDA issues complete response letter denying approval to Targanta's NDA for oritavancin
Read More
Adult lymphoma research group chooses Revlimid for phase III study
Read More
Affymetrix completes acquisition of assay company, Panomics
Read More
Cancer vaccine HSPPC-96 invokes responses in phase I glioma trial
Read More
Ozarelix's effects on histamine release assessed, administration routes compared
Read More
Adeno-associated virus liver-directed gene therapy effective in hyperbilirubinemia model
Read More
Kiadis Pharma receives two FDA orphan drug designations for Reviroc
Read More
MAA for Medivir's Lipsovir validated by American and European regulatory authorities
Read More
Clinical evaluation of BIW-8962 encouraged by activity in preclinical myeloma models
Read More
Sosei reports positive results from two phase I trials of SD-118 for neuropathic pain
Read More
Haemacure reports results from preclinical study of fibrin sealant Hemaseel HMN
Read More
FDA approves Quintessence's IND to initiate phase I trial of QBI-139 in solid tumors
Read More
Pfizer and Sigma-Tau sign license agreement for ACT malaria drug Eurartesim in Africa
Read More
HGS reports results from phase III clinical trial of Albuferon in patients with chronic hepatitis C
Read More
New treatment options for genitourinary disorders reported in recent Japanese patents
Read More
Studies with AVL-101 highlight Bruton's tyrosine kinase as a target in B-cell lymphoma
Read More